These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 27815935)

  • 61. A systematic review of hepatitis B screening economic evaluations in low- and middle-income countries.
    Wright CM; Boudarène L; Ha NT; Wu O; Hawkins N
    BMC Public Health; 2018 Mar; 18(1):373. PubMed ID: 29558894
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effectiveness of Interventions for Hepatitis B and C: A Systematic Review of Vaccination, Screening, Health Promotion and Linkage to Care Within Higher Income Countries.
    Ortiz E; Scanlon B; Mullens A; Durham J
    J Community Health; 2020 Feb; 45(1):201-218. PubMed ID: 31332639
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A Rapid Review of Interventions to Increase Hepatitis B Testing, Treatment, and Monitoring among Migrants Living in Australia.
    Rajkumar V; McCausland K; Lobo R
    Int J Environ Res Public Health; 2022 May; 19(10):. PubMed ID: 35627481
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Point-of-Care Tests for Hepatitis B: An Overview.
    Xiao Y; Thompson AJ; Howell J
    Cells; 2020 Oct; 9(10):. PubMed ID: 33023265
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Hepatitis C screening and testing: a call for a national response.
    Zucker DM;
    Nurs Outlook; 2012; 60(4):229-30. PubMed ID: 22977894
    [No Abstract]   [Full Text] [Related]  

  • 66. Hepatitis of unknown origin in children: Updated evidence and concise review.
    Jha AK
    J Viral Hepat; 2022 Nov; 29(11):942-947. PubMed ID: 36062362
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cancer Burden Variations and Convergences in Globalization: A Comparative Study on the Tracheal, Bronchus, and Lung (TBL) and Liver Cancer Burdens Among WHO Regions from 1990 to 2019.
    Zhang M; Jin W; Tian Y; Zhu H; Zou N; Jia Y; Jiang L; Huang J; Hu Y; Luo Q
    J Epidemiol Glob Health; 2023 Dec; 13(4):696-724. PubMed ID: 37639192
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Non-disclosure of drug injection practices as a barrier to HCV testing: results from the PrebupIV community-based research study.
    Anwar I; Donadille C; Protopopescu C; Michels D; Herin J; Pladys A; Bader D; Carrieri P; Roux P
    Harm Reduct J; 2023 Jul; 20(1):98. PubMed ID: 37516889
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A hepatitis C elimination model in healthcare for the homeless organization: A novel reflexive laboratory algorithm and equity assessment.
    Seaman A; King CA; Kaser T; Geduldig A; Ronan W; Cook R; Chan B; Levander XA; Priest KC; Korthuis PT
    Int J Drug Policy; 2021 Oct; 96():103359. PubMed ID: 34325969
    [TBL] [Abstract][Full Text] [Related]  

  • 70. HepCare Europe: a new user-friendly hepatitis C care service model. What have we learned? What are the remaining challenges?
    Rockstroh JK; Yazdanpanah Y
    J Antimicrob Chemother; 2019 Nov; 74(Suppl 5):v2-v4. PubMed ID: 31782498
    [No Abstract]   [Full Text] [Related]  

  • 71. Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework.
    Day E; Hellard M; Treloar C; Bruneau J; Martin NK; Øvrehus A; Dalgard O; Lloyd A; Dillon J; Hickman M; Byrne J; Litwin A; Maticic M; Bruggmann P; Midgard H; Norton B; Trooskin S; Lazarus JV; Grebely J;
    Liver Int; 2019 Jan; 39(1):20-30. PubMed ID: 30157316
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Approaches for simplified HCV diagnostic algorithms.
    Fourati S; Feld JJ; Chevaliez S; Luhmann N
    J Int AIDS Soc; 2018 Apr; 21 Suppl 2(Suppl Suppl 2):e25058. PubMed ID: 29633561
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?
    Grebely J; Dore GJ; Morin S; Rockstroh JK; Klein MB
    J Int AIDS Soc; 2017 Jul; 20(1):22146. PubMed ID: 28782335
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Research priorities to achieve universal access to hepatitis C prevention, management and direct-acting antiviral treatment among people who inject drugs.
    Grebely J; Bruneau J; Lazarus JV; Dalgard O; Bruggmann P; Treloar C; Hickman M; Hellard M; Roberts T; Crooks L; Midgard H; Larney S; Degenhardt L; Alho H; Byrne J; Dillon JF; Feld JJ; Foster G; Goldberg D; Lloyd AR; Reimer J; Robaeys G; Torrens M; Wright N; Maremmani I; Norton BL; Litwin AH; Dore GJ;
    Int J Drug Policy; 2017 Sep; 47():51-60. PubMed ID: 28683982
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Are the testing needs of key European populations affected by hepatitis B and hepatitis C being addressed? A scoping review of testing studies in Europe.
    Lazarus JV; Sperle I; Spina A; Rockstroh JK
    Croat Med J; 2016 Oct; 57(5):442-456. PubMed ID: 27815935
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hepatitis B and C surveillance and screening programmes in the non-EU/EEA Member States of the WHO European Region: survey findings from 10 countries, 2012.
    Mozalevskis A; Eramova I; Safreed-Harmon K; Lazarus JV
    Euro Surveill; 2016 Jun; 21(22):. PubMed ID: 27277421
    [TBL] [Abstract][Full Text] [Related]  

  • 77. 2014 French guidelines for hepatitis B and C screening: a combined targeted and mass testing strategy of chronic viruses namely HBV, HCV and HIV.
    Bottero J; Brouard C; Roudot-Thoraval F; Deuffic-Burban S; Hofliger P; Abergel A; Volant J; Dhumeaux D; Yazdanpanah Y;
    Liver Int; 2016 Oct; 36(10):1442-9. PubMed ID: 27043826
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hepatitis B and C testing strategies in healthcare and community settings in the EU/EEA: A systematic review.
    Mason LMK; Veldhuijzen IK; Duffell E; van Ahee A; Bunge EM; Amato-Gauci AJ; Tavoschi L
    J Viral Hepat; 2019 Dec; 26(12):1431-1453. PubMed ID: 31332919
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.